
Keywords: metabolomics; phospholipids; plasma biomarkers; restenosis; sphingomyelins; ISR; in-stent restenosis; IVUS; intravascular ultrasound; MRM; multiple reaction monitoring; PCI; percutaneous coronary intervention; QCA; quantitative coronary analysis; S1P; sph